Bausch Health
BHC
#4602
Rank
A$3.12 B
Marketcap
A$8.41
Share price
-4.20%
Change (1 day)
-18.07%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): A$1.48

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is A$1.38. In 2024 the company made an earnings per share (EPS) of A-$0.17 an increase over its 2023 EPS that were of A-$2.30.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$1.48-969.39%
2024A-$0.17-92.59%
2023A-$2.30160.89%
2022A-$0.88-76.64%
2021A-$3.7768.45%
2020A-$2.24-68.91%
2019A-$7.20-57.11%
2018A-$16.78-272.22%
2017A$9.75-199.29%
2016A-$9.82798.7%
2015A-$1.09-128.31%
2014A$3.86-204.62%
2013A-$3.69602.7%
2012A-$0.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.34-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.35-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA